Press release
Global Biomarkers Market Forecast: Reaching $104.15 Billion by 2030
By PCR technology, the biomarkers market is segmented by technology into immunoassays, NGS, PCR, mass spectrometry, chromatography, and other technologies. PCR technology, which is used for detecting, quantifying, and validating nucleic acid-based biomark
The global [https://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html] is undergoing a rapid transformation, driven by advances in drug development, precision medicine, and companion diagnostics. Valued at US$58.07 billion in 2024, the market reached US$62.39 billion in 2025 and is projected to grow at a robust CAGR of 10.8% from 2025 to 2030, reaching US$104.15 billion by the end of the forecast period. This exponential rise underscores the critical role biomarkers play in enabling personalized treatment pathways, early disease detection, and clinical decision-making.
Market Growth Insights & Trends
Biomarkers have become essential tools in healthcare innovation. Their use in oncology, neurology, cardiology, and infectious diseases is reshaping diagnostics and therapeutics.
* Market Size & Forecast: $62.39 billion in 2025 right $104.15 billion by 2030.
* Growth Drivers: Increasing adoption of companion diagnostics and expansion of clinical trials leveraging biomarker data.
[https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43]
Key Market Drivers
Several forces are propelling the biomarkers market growth:
* Rising Role of Companion Diagnostics - Biomarkers are central to tailoring therapies for individual patients, especially in oncology.
* Advancements in Precision Medicine - The demand for patient-specific treatment approaches continues to expand.
* Drug Development & Clinical Trials - Pharmaceutical companies increasingly rely on biomarkers to identify responders, reduce trial costs, and improve approval timelines.
* Technological Innovations - Integration of AI, next-gen sequencing, and bioinformatics in biomarker research is accelerating discoveries.
Challenges & Opportunities
Despite strong growth, the biomarkers market faces obstacles:
* Regulatory Hurdles - Complex approval processes can delay biomarker commercialization.
* High R&D Costs - Developing biomarker assays requires substantial investment.
* Data Standardization Issues - Harmonization of biomarker data across clinical settings remains limited.
However, opportunities abound in:
* Liquid Biopsies - Non-invasive diagnostics are emerging as game changers.
* Biomarker-Based Therapies - Accelerating demand in oncology, rare diseases, and autoimmune conditions.
* Global Collaborations - Partnerships between pharma, biotech, and diagnostic companies are shaping the next wave of innovations.
Competitive Landscape
The biomarkers market is highly competitive, with global players investing heavily in R&D, partnerships, and acquisitions. Major companies include:
* Roche Diagnostics
* Thermo Fisher Scientific
* Abbott Laboratories
* Siemens Healthineers
* Bio-Rad Laboratories
* Qiagen N.V.
These companies are focusing on expanding biomarker assays, advancing companion diagnostics, and leveraging AI in biomarker discovery.
[https://www.marketsandmarkets.com/requestsampleNew.asp?id=43]
Future Outlook: Biomarkers Market 2030
Looking ahead, the biomarkers industry forecast points toward a future shaped by:
* Wider adoption of digital biomarkers for remote monitoring and chronic disease management.
* Next-generation sequencing (NGS) biomarkers integrated with clinical workflows.
* Increased role in preventive healthcare with early detection and risk assessment models.
* AI-powered biomarker discovery platforms reducing research timelines and costs.
By 2030, biomarkers will not just support diagnostics but become the backbone of global precision medicine.
Conclusion
The biomarkers market is on track to surpass US$104 billion by 2030, fueled by breakthroughs in drug development, diagnostics, and precision medicine. Companies that invest in innovation, partnerships, and data-driven biomarker research will be best positioned to capitalize on this rapidly evolving market.
For healthcare innovators, biotech leaders, and investors, now is the time to explore opportunities in the global biomarkers industry.
[https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=43]
Frequently Asked Questions (FAQs)
1. What is driving the growth of the biomarkers market? The key drivers include rising demand for precision medicine, growing use of companion diagnostics, and biomarker-based drug development.
2. How big is the biomarkers market expected to be by 2030? The market is projected to reach US$104.15 billion by 2030, growing at a CAGR of 10.8% from 2025.
3. Which industries benefit the most from biomarkers? Pharmaceuticals, biotechnology, diagnostics, and clinical research organizations (CROs) are the main beneficiaries.
4. Who are the major players in the biomarkers market? Key players include Roche, Thermo Fisher Scientific, Abbott, Siemens Healthineers, Bio-Rad, and Qiagen.
5. What role do biomarkers play in precision medicine? Biomarkers enable personalized treatment pathways, better patient stratification, and targeted therapy development.
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-biomarkers-market-forecast-reaching-10415-billion-by-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biomarkers Market Forecast: Reaching $104.15 Billion by 2030 here
News-ID: 4296241 • Views: …
More Releases from ABNewswire
Oligonucleotide Synthesis Market Forecast 2025-2030: Growth Trends, Key Drivers …
The global oligonucleotide synthesis market is projected to grow from US$10.5 billion in 2025 to US$24.7 billion by 2030 at a CAGR of 18.6%. Explore key trends, drivers, opportunities, and leading companies shaping this booming sector.
Why Oligonucleotide Synthesis Matters in 2025
The global [https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html] is entering a high-growth phase, fueled by advancements in genomics, therapeutics, and diagnostics. Valued at US$8.9 billion in 2024, the market reached US$10.5 billion in 2025 and…
Pumps Industry: Key Players, Market Share, and Emerging Trends | Grundfos Holdin …
The global pumps industry will reach $79.01 B by 2029, growing at 5.2% CAGR. Led by Grundfos, Xylem, Flowserve & KSB. Smart tech & energy efficiency drive growth in water, oil & gas sectors.
The global pumps industry [https://www.marketsandmarkets.com/Market-Reports/pumps-market-29873540.html] is experiencing robust growth, driven by rapid industrialization, urbanization, and increasing infrastructure development worldwide. The market was valued at approximately USD 61.32 billion in 2024 and is projected to reach USD 79.01…
Latest Research on Material in the Control Valve Market by MarketsandMarkets Tra …
The global Control Valve Market Size in terms of revenue is estimated to be worth $10.42 billion in 2025 and is poised to reach $13.30 billion by 2030, growing at a CAGR of 5.0% during the forecast period.
MarketsandMarkets has announced the release of its latest research report on the Global Control Valve Market [https://www.marketsandmarkets.com/Market-Reports/control-valves-market-111759647.html?utm_source=abnewswire.com&utm_medium=PaidPR&utm_campaign=controlvalvemarket], which is projected to expand from USD 10.42 billion in 2025 to USD 13.30 billion by…
EV Connector Market worth $8.80 billion by 2032
EV Connector Market by System (Sealed, Unsealed), Application (ADAS & Safety, Battery Management, Body Control & Interiors), Propulsion (BEV, PHEV, FCEV), Voltage, Connection, Component, and Region - Global Forecast to 2032
The EV connector market [https://www.marketsandmarkets.com/Market-Reports/ev-connector-market-59111615.html] is projected to reach USD 8.80 billion by 2032, from USD 2.73 billion in 2025, with a CAGR of 18.2%.
EV connectors for high-voltage systems are increasingly required to support miniaturization, weight reduction, and high-performance materials,…
More Releases for PCR
Emerging Trends to Reshape the Global Real-Time PCR, Digital PCR And End-Point P …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Real-Time PCR, Digital PCR And End-Point PCR Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing real-time PCR, digital PCR, and end-point PCR has experienced robust expansion over the past few years, projecting a rise from $38.37 billion in 2024 to $41.55 billion…
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
The PCR And Realtime PCR Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current PCR And Realtime PCR Testing Market Size and Its Estimated Growth Rate?
The PCR and real-time PCR testing market has grown strongly, rising from $10.55 billion in 2024…
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size?
There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is…
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size?
There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is…
Q-PCR and D-PCR Devices Market: Revolutionizing Molecular Diagnostics
The Q-PCR and D-PCR devices market has experienced significant growth in recent years, driven by advancements in molecular biology and the increasing demand for accurate and sensitive diagnostic tools. These technologies have revolutionized the field of molecular diagnostics, enabling researchers and clinicians to detect and quantify specific DNA or RNA sequences with high precision.
Market Size and Growth
The global Q-PCR and D-PCR devices market is estimated to be worth billions of…
Real-Time PCR, Digital PCR And End-Point PCR Global Market Analysis, Trends, Gro …
The new report published by The Business Research Company, titled "Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the real-time pcr, digital pcr and end-point pcr market size has grown strongly…
